Wednesday May 27, 2020

Merrion Pharmaceuticals announces liquidation plan

Company could have around €4.5m to distribute to shareholders

22nd August, 2016
Dr John Fox to leave Merrion Pharmaceuticals after EGM. PIcture: Feargal Ward

The board of Dublin-listed Merrion Pharmaceuticals has proposed that the company be wound up, with its remaining funds distributed to shareholders.

In a statement today, however, Merrion said its board had looked at a number of investment proposals, none of which were thought "sufficiently compelling" to recommend to shareholders.

The board said a statutory declaration of solvency for the company indicated that around €4.5m was available to shareholders from the proposed liquidation, though this figure...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The former NTMA head says he is ‘quite alarmed’ at the potential for legal actions over the large number of deaths in nursing homes during the crisis

Michael Brennan | 3 weeks ago

Oil storage in the self-styled ‘Pipeline Crossroads of the World’ is full to the brim, but the black stuff keeps on coming. With much of the world’s economy in a Covid-19 slowdown, at one point last week, benchmark US crude oil was priced at minus $37.63 a barrel

Barry J Whyte | 1 month ago

Every time Donald Trump spoke on the Covid-19 crisis last week, the stock markets plunged by another point

Marion McKeone | 2 months ago